EligibleTrials

GV20-0251 and Pembrolizumab [KEYTRUDA®]: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
10
Conditions studied
12
US states with sites
1
Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

ConditionTrials
Colorectal cancer1
Cutaneous Melanoma1
Endometrial Carcinoma (EC)1
Lung cancer1
Melanoma1
Non-Small Cell Lung Cancer1
Refractory Cancer1
Solid Tumor, Adult1
Squamous Head and Neck Carcinoma1
pMMR/MSS Adenocarcinoma of the Colon or Rectum1

Recruiting trials involving GV20-0251 and Pembrolizumab [KEYTRUDA®]

Common questions

How many recruiting trials involve GV20-0251 and Pembrolizumab [KEYTRUDA®]?

1 recruiting trial across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.